A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

• Status: Completed
• Trial end date: 2012-12-01

Summary

The objective of this study is:

To evaluate the pharmacokinetics and safety of an experimental combination tablet containing 20 mg atorvastatin and 50 mg losartan potassium when administered orally as a single dose to healthy male subjects, compared with the concomitant administration of 20 mg atorvastatin and 50 mg losartan potassium tablets.

• Phase: Phase 1

Details

• Lead Sponsor: HanAll BioPharma Co., Ltd.
• Treatments: Atorvastatin; Atorvastatin Calcium; Losartan